Testing the Combination of Belinostat and SGI-110 (Guadecitabine) for the Treatment of Unresectable and Metastatic Conventional Chondrosarcoma
Conditions: Metastatic Primary Central Chondrosarcoma; Unresectable Primary Central Chondrosarcoma Interventions: Drug: Belinostat; Drug: Guadecitabine Sponsor: National Cancer Institute (NCI) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials